Evoq Remedies Limited (BOM:543500)

Evoq Remedies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	3.08	2.14	1.23	1.54	30.94	0.33
Cash & Short-Term Investments	3.08	2.14	1.23	1.54	30.94	0.33
Cash Growth	18.89%	73.50%	-19.66%	-95.04%	9179.27%	1415.67%
Accounts Receivable	43.9	86.17	17.43	172.16	253.98	68.36
Receivables	370.45	365.28	332.78	250.85	291.33	77.06
Inventory	19.88	22.19	31.25	20.32	7.84	1.51
Other Current Assets	126.77	108.25	3.21	76.19	3.2	1.56
Total Current Assets	520.18	497.86	368.47	348.89	333.31	80.46
Property, Plant & Equipment	1.97	2.23	0.14	0.09	-	-
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	522.15	500.09	368.61	348.99	333.31	80.46
Accounts Payable	7.59	34.97	32.83	-5.37	12.09	67.83
Accrued Expenses	7.52	3.2	0.1	0.12	4.31	2.02
Short-Term Debt	-	-	42.38	95.76	81.58	-
Current Income Taxes Payable	-	7.2	8.14	8.67	3.67	2.38
Other Current Liabilities	61.13	9.37	32.78	1.95	-	0.79
Total Current Liabilities	76.25	54.73	116.23	101.13	101.65	73.02
Long-Term Debt	-	-	-	-	-	0.01
Total Liabilities	76.25	54.73	116.23	101.13	101.65	73.03
Common Stock	249	249	136	136	136	0.1
Additional Paid-In Capital	-	163.52	84.42	84.42	84.42	-
Retained Earnings	-	32.84	31.96	27.44	11.24	7.33
Shareholders' Equity	445.9	445.36	252.38	247.86	231.66	7.43
Total Liabilities & Equity	522.15	500.09	368.61	348.99	333.31	80.46
Total Debt	-	-	42.38	95.76	81.58	0.01
Net Cash (Debt)	3.08	2.14	-41.15	-94.23	-50.64	0.32
Net Cash Per Share	0.12	0.09	-3.03	-6.93	-5.06	0.32
Filing Date Shares Outstanding	27.15	24.9	13.6	13.6	13.6	0.71
Total Common Shares Outstanding	27.15	24.9	13.6	13.6	13.6	0.71
Working Capital	443.94	443.13	252.24	247.76	231.66	7.44
Book Value Per Share	16.42	17.89	18.56	18.22	17.03	10.47
Tangible Book Value	445.9	445.36	252.38	247.86	231.66	7.43
Tangible Book Value Per Share	16.42	17.89	18.56	18.22	17.03	10.47
Machinery	-	-	-	0.13	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.